Hudson Bay Capital Management
KRTX

Hudson Bay Capital Management’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

Hudson Bay Capital Management’s Portfolio KRTX Stock Details KRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-40,000
Closed -$12.7M – 949
2023
Q4 		$12.7M Buy
40,000
+20,000
+100% +$3.89M 0.08% 152
2023
Q3 		$3.38M Buy
+20,000
New +$3.76M 0.03% 379

Other funds holding KRTX

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
S
Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return

Hudson Bay Capital Management's KRTX Position: Q1 2024 in Review

Hudson Bay Capital Management sold out of Karuna Therapeutics, Inc. Common Stock (KRTX) in Q1 2024, closing a stake of 40,000 shares — an estimated $12.7M sold.

Hudson Bay Capital Management first reported a position in KRTX in Q3 2023 and held it in 2 quarters. The position peaked at $12.7M in Q4 2023. 2 funds tracked by Wall St. Rank hold KRTX as of Q1 2024.

  • Hudson Bay Capital Management reported no remaining Karuna Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Hudson Bay Capital Management sold 40,000 Karuna Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $12.7M.
  • Hudson Bay Capital Management first reported a position in Karuna Therapeutics, Inc. Common Stock in Q3 2023 and held it in 2 quarters.
  • Hudson Bay Capital Management's Karuna Therapeutics, Inc. Common Stock position peaked at $12.7M in Q4 2023.
  • 2 funds tracked by Wall St. Rank held Karuna Therapeutics, Inc. Common Stock as of Q1 2024.

Based on Hudson Bay Capital Management's 13F filing for Q1 2024, filed 15 May 2024.